+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Drug Compounding Market Size, Share & Trends Analysis Report by Product, Animal Type, Route of Administration, Dosage Form, Region, and Segment Forecasts, 2026-2033- Product Image
Animal Drug Compounding Market Size, Share & Trends Analysis Report by Product, Animal Type, Route of Administration, Dosage Form, Region, and Segment Forecasts, 2026-2033- Product Image
New

Animal Drug Compounding Market Size, Share & Trends Analysis Report by Product, Animal Type, Route of Administration, Dosage Form, Region, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • February 2026
  • Region: Global
  • Grand View Research
  • ID: 5767757
REQUEST CUSTOMIZATION
Description Jump to:
The global animal drug compounding market size was estimated at USD 1.68 billion in 2025 and is projected to reach USD 3.25 billion by 2033, growing at a CAGR of 8.52% from 2026 to 2033. The market is advancing due to increasing demand for personalized veterinary therapies, shortages and discontinuation of commercial veterinary drugs and rising pet ownership and veterinary spending.

Rising complexity in veterinary care is driving demand for personalized drug formulations customized to diverse animal needs. The standardized medications often fail to provide precise dosing, suitable delivery routes, or acceptable palatability. Besides this, compounding enables veterinarians to adjust strength, formulation, excipients, and flavor, improving compliance and therapeutic outcomes. In addition, personalized therapies are particularly important for small mammals, geriatric animals, and chronic cases requiring long-term treatment. In addition, compounded drugs can be prepared as flavored suspensions, micro-dosed capsules, or transdermal gels to match species-specific requirements.

In addition, ongoing supply disruptions and discontinuation of veterinary drugs are increasing reliance on compounding to maintain continuity of care. The market withdrawals due to limited demand, manufacturing challenges, or regulatory changes often leave treatment gaps, particularly for niche species and specialized conditions. Besides this, veterinary compounding enables pharmacists to recreate discontinued medications or prepare therapeutic alternatives, ensuring uninterrupted access to essential therapies. This is especially critical for chronic, geriatric, and specialty treatments with limited commercial substitutes. In addition, growing supply chain volatility, raw material shortages, and shifting manufacturing priorities have made compounding an indispensable support system, particularly for rural veterinary practices and specialty clinics facing constrained drug availability.

Furthermore, rising global pet ownership, particularly among urban and middle-income households, is driving increased demand for veterinary care and personalized treatments. Besides this, pets are regarded as family members, encouraging higher spending on diagnostics, preventive care, and specialized therapies. Thus, compounded medications provide flexible, veterinarian-directed solutions when standard commercial products are unsuitable, especially for chronic diseases, pain management, and geriatric conditions. In addition, veterinary spending continues to grow across North America, Western Europe, and Asia Pacific, supported by rising disposable incomes and expanding pet insurance coverage. In the U.S., widespread pet ownership across multiple species further strengthens demand for customized, species-specific compounded formulations.

Global Animal Drug Compounding Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global animal drug compounding market report based on product, animal, route of administration, dosage form, and region:

Route of Administration Outlook (Revenue, USD Million, 2021-2033)

  • Oral
  • Injectable
  • Topical
  • Other Routes

Animal Outlook (Revenue, USD Million, 2021-2033)

  • Companion Animals
  • Livestock Animals

Product Outlook (Revenue, USD Million, 2021-2033)

  • Anti-infective Agents
  • Anti-inflammatory Agents
  • Hormones & Substitutes
  • CNS Agents
  • Other Products

Dosage Form Outlook (Revenue, USD Million, 2021-2033)

  • Suspensions
  • Solutions
  • Capsules & Tablets
  • Others

Region Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Route of Administration
1.2.2. Product
1.2.3. Animal
1.2.4. Dosage Form
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information/Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Model 1: Commodity Flow Analysis
1.7.2. Model 2: Bottom-Up Analysis
1.7.3. Model 3 Volume-Pricing Analysis
1.8. List of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary/Related Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Demand for Personalized Veterinary Therapies
3.2.1.2. Shortages And Discontinuation of Commercial Veterinary Drugs
3.2.1.3. Rising Pet Ownership and Veterinary Spending
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of Standardized Regulatory Oversight
3.2.2.2. High Cost and Limited Accessibility of Compounded Medications
3.2.3. Market Opportunity Analysis
3.3. Pricing Model Analysis
3.4. User Perspective Analysis
3.5. Estimated Animal Population by Key Species & Key Countries, 2025
3.6. Market Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTEL by SWOT Analysis
3.7. Tariff Impact Analysis
3.7.1. Sector Impact Analysis
3.7.2. Geographical Impact Analysis
3.7.3. Strategic Opportunities & Risk for the Animal Drug Compounding Sector
3.8. Illegally Marketed Veterinary Drug Compounding Analysis
Chapter 4. Animal Drug Compounding Market: By Route of Administration Estimates & Trend Analysis
4.1. Animal Drug Compounding Market, By Route of Administration: Segment Dashboard
4.2. Animal Drug Compounding Market, By Route of Administration Movement Analysis
4.3. Animal Drug Compounding Market Estimates & Forecasts, by Route of Administration, 2021 to 2033 (USD Million)
4.4. Oral
4.4.1. Oral Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Injectable
4.5.1. Injectable Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Topical
4.6.1. Topical Market Estimates and Forecasts, 2021-2033 (USD Million)
4.7. Other Routes
4.7.1. Other Routes Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Animal Drug Compounding Market: By Animal Estimates & Trend Analysis
5.1. Animal Drug Compounding Market, By Animal: Segment Dashboard
5.2. Animal Drug Compounding Market, By Animal Movement Analysis
5.3. Animal Drug Compounding Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
5.4. Companion Animals
5.4.1. Companion Animals Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.2. Dogs
5.4.2.1. Dogs Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.3. Cats
5.4.3.1. Cats Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.4. Others
5.4.4.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Livestock Animals
5.5.1. Livestock Animals Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Animal Drug Compounding Market: By Product Estimates & Trend Analysis
6.1. Animal Drug Compounding Market, By Product: Segment Dashboard
6.2. Animal Drug Compounding Market, By Product Movement Analysis
6.3. Animal Drug Compounding Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
6.4. Anti-infective Agents
6.4.1. Anti-infective Agents Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Anti-inflammatory Agents
6.5.1. Anti-inflammatory Agents Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Hormones & Substitutes
6.6.1. Hormones & Substitutes Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. CNS Agents
6.7.1. CNS Agents Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Other Products
6.8.1. Other Products Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Animal Drug Compounding Market: By Dosage Form Estimates & Trend Analysis
7.1. Animal Drug Compounding Market, By Dosage Form: Segment Dashboard
7.2. Animal Drug Compounding Market, By Dosage Form Movement Analysis
7.3. Animal Drug Compounding Market Estimates & Forecasts, by Dosage Form, 2021 to 2033 (USD Million)
7.4. Suspensions
7.4.1. Suspensions Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Solutions
7.5.1. Solutions Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Capsules & Tablets
7.6.1. Capsules & Tablets Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Others
7.7.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Animal Drug Compounding Market: By Regional Estimates & Trend Analysis
8.1. Region Market Dashboard
8.2. Region Market Share Analysis, 2025 & 2033
8.3. North America
8.3.1. North America Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.2. U.S
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. U.S. Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Canada Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.4. Mexico
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Mexico Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4. Europe
8.4.1. Europe Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. UK Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Germany Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.4. France
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. France Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.5. Italy
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Italy Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.6. Spain
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Spain Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.7. Denmark
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Denmark Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Sweden Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Framework
8.4.9.4. Norway Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5. Asia Pacific
8.5.1. Asia Pacific Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5.2. Japan
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Japan Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. China Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. India Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5.5. Australia
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Australia Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5.6. Thailand
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Thailand Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5.7. South Korea
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. South Korea Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6. Latin America
8.6.1. Latin America Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Brazil Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6.3. Argentina
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Argentina Market Estimates and Forecasts, 2021-2033 (USD Million)
8.7. MEA
8.7.1. MEA Market Estimates and Forecasts, 2021-2033 (USD Million)
8.7.2. South Africa
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. South Africa Market Estimates and Forecasts, 2021-2033 (USD Million)
8.7.3. UAE
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. UAE Market Estimates and Forecasts, 2021-2033 (USD Million)
8.7.4. Saudi Arabia
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021-2033 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Kuwait Market Estimates and Forecasts, 2021-2033 (USD Million)
8.7.6. Qatar
8.7.6.1. Key Country Dynamics
8.7.6.2. Competitive Scenario
8.7.6.3. Regulatory Framework
8.7.6.4. Qatar Market Estimates and Forecasts, 2021-2033 (USD Million)
8.7.7. Oman
8.7.7.1. Key Country Dynamics
8.7.7.2. Competitive Scenario
8.7.7.3. Regulatory Framework
8.7.7.4. Oman Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.1.1. Market Leaders
9.1.2. Emerging Players
9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
9.3. Company Profiles
9.3.1. WEDGEWOOD PHARMACY
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product/Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Vimian
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product/Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Pharmaca
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product/Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Akina Animal Health
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product/Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Triangle Compunding
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product/Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Davis Island Pharmacy and Compounding Lab
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product/Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Custom Med Compounding Pharmacy
9.3.7.1. Participant’s Overview
9.3.7.2. Financial Performance
9.3.7.3. Product/Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Central Compounding Center South
9.3.8.1. Participant’s Overview
9.3.8.2. Financial Performance
9.3.8.3. Product/Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Wellness Pharmacy of Cary
9.3.9.1. Participant’s Overview
9.3.9.2. Financial Performance
9.3.9.3. Product/Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Miller’s Pharmacy
9.3.10.1. Participant’s Overview
9.3.10.2. Financial Performance
9.3.10.3. Product/Service Benchmarking
9.3.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Global Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 4 Global Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 5 Global Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 6 Global Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 7 North America Animal Drug Compounding Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 8 North America Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 9 North America Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 10 North America Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 11 North America Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 12 U.S. Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 13 U.S.Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 14 U.S.Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 15 U.S. Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 16 Canada Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 17 Canada Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 18 Canada Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 19 Canada Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 20 Mexico Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 21 Mexico Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 22 Mexico Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 23 Mexico Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 24 Europe Animal Drug Compounding Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 25 Europe Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 26 Europe Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 27 Europe Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 28 Europe Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 29 UK Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 30 UK Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 31 UK Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 32 UK Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 33 Germany Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 34 Germany Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 35 Germany Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 36 Germany Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 37 France Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 38 France Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 39 France Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 40 France Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 41 Italy Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 42 Italy Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 43 Italy Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 44 Italy Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 45 Spain Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 46 Spain Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 47 Spain Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 48 Spain Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 49 Denmark Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 50 Denmark Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 51 Denmark Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 52 Denmark Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 53 Sweden Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 54 Sweden Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 55 Sweden Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 56 Sweden Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 57 Norway Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 58 Norway Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 59 Norway Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 60 Norway Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 61 Asia Pacific Animal Drug Compounding Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 62 Asia Pacific Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 63 Asia Pacific Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 64 Asia Pacific Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 65 Asia Pacific Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 66 Japan Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 67 Japan Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 68 Japan Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 69 Japan Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 70 China Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 71 China Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 72 China Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 73 China Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 74 India Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 75 India Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 76 India Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 77 India Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 78 Australia Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 79 Australia Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 80 Australia Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 81 Australia Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 82 Thailand Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 83 Thailand Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 84 Thailand Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 85 Thailand Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 86 South Korea Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 87 South Korea Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 88 South Korea Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 89 South Korea Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 90 Latin America Animal Drug Compounding Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 91 Latin America Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 92 Latin America Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 93 Latin America Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 94 Latin America Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 95 Brazil Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 96 Brazil Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 97 Brazil Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 98 Brazil Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 99 Argentina Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 100 Argentina Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 101 Argentina Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 102 Argentina Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 103 Middle East & Africa Animal Drug Compounding Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 104 Middle East & Africa Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 105 Middle East & Africa Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 106 Middle East & Africa Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 107 Middle East & Africa Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 108 South Africa Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 109 South Africa Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 110 South Africa Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 111 South Africa Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 112 UAE Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 113 UAE Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 114 UAE Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 115 UAE Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 116 Saudi Arabia Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 117 Saudi Arabia Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 118 Saudi Arabia Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 119 Saudi Arabia Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 120 Kuwait Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 121 Kuwait Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 122 Kuwait Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 123 Kuwait Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 124 Qatar Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 125 Qatar Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 126 Qatar Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 127 Qatar Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
Table 128 Oman Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 129 Oman Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021-2033 (USD Million)
Table 130 Oman Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021-2033 (USD Million)
Table 131 Oman Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021-2033 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Market Formulation & Validation
Figure 6 Commodity Flow Analysis
Figure 7 Value Chain-Based Sizing & Forecasting
Figure 8 QFD Model Sizing & Forecasting
Figure 9 Bottom-Up Approach
Figure 10 Market Snapshot
Figure 11 Segment Snapshot 1
Figure 12 Segment Snapshot 2
Figure 13 Competitive Landscape Snapshot
Figure 14 Parent Market Outlook, 2025 (USD Billion)
Figure 15 Ancillary Market Outlook, 2025 (USD Billion)
Figure 16 Animal Drug Compounding Market Dynamics
Figure 17 Porter’s Five Forces Analysis
Figure 18 PESTEL Analysis
Figure 19 Animal Drug Compounding Market: Product Outlook and Key Takeaways
Figure 20 Animal Drug Compounding Market: Product Movement Analysis
Figure 21 Anti-infective Agents Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 22 Anti-inflammatory Agents Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 23 Hormones & Substitutes Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 24 CNS Agents Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 25 Other Products Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 26 Animal Drug Compounding Market: Animal Outlook and Key Takeaways
Figure 27 Animal Drug Compounding Market: Animal Movement Analysis
Figure 28 Companion Animals Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 29 Dogs Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 30 Cats Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 31 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 32 Livestock Animals Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 33 Animal Drug Compounding Market: Route of Administration Outlook and Key Takeaways
Figure 34 Animal Drug Compounding Market: Route of Administration Movement Analysis
Figure 35 Oral Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 36 Injectable Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 37 Topical Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 38 Other Routes Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 39 Animal Drug Compounding Market: Distribution Channel Outlook and Key Takeaways
Figure 40 Animal Drug Compounding Market: Distribution Channel Movement Analysis
Figure 41 Suspensions Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 42 Solutions Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 43 Capsules & Tablets Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 44 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 45 Regional Marketplace: Key Takeaways
Figure 46 North America Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 47 Key country dynamics
Figure 48 U.S. Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 49 Key country dynamics
Figure 50 Canada Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 51 Key country dynamics
Figure 52 Mexico Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 53 Key country dynamics
Figure 54 Europe Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 55 Key country dynamics
Figure 56 UK Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 57 Key country dynamics
Figure 58 Germany Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 59 Key country dynamics
Figure 60 France Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 61 Key country dynamics
Figure 62 Italy Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 63 Key country dynamics
Figure 64 Spain Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 65 Key country dynamics
Figure 66 Denmark Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 67 Key country dynamics
Figure 68 Sweden Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 69 Key country dynamics
Figure 70 Norway Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 71 Asia Pacific Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 72 Key country dynamics
Figure 73 Japan Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 74 Key country dynamics
Figure 75 China Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 76 Key country dynamics
Figure 77 India Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 78 Key country dynamics
Figure 79 Australia Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 80 Key country dynamics
Figure 81 Thailand Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 82 Key country dynamics
Figure 83 South Korea Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 84 Latin America Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 85 Key country dynamics
Figure 86 Brazil Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 87 Key country dynamics
Figure 88 Argentina Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 89 MEA Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 90 Key country dynamics
Figure 91 South Africa Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 92 Key country dynamics
Figure 93 UAE Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 94 Key country dynamics
Figure 95 Saudi Arabia Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 96 Key country dynamics
Figure 97 Kuwait Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 98 Key country dynamics
Figure 99 Qatar Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 100 Key country dynamics
Figure 101 Oman Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)

Companies Mentioned

The leading players profiled in this Animal Drug Compounding market report include:
  • WEDGEWOOD PHARMACY
  • Vimian
  • Pharmaca.
  • Akina Animal Health
  • Triangle Compounding.
  • Davis Islands Pharmacy and Compounding Lab
  • Custom Med Compounding Pharmacy
  • Central Compounding Center South
  • Wellness Pharmacy of Cary
  • Miller's Pharmacy

Table Information

Report AttributeDetails
No. of Pages150
PublishedFebruary 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 1.68 Billion
Forecasted Market Value ( USD ) by 2033 $ 3.25 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Animal Drug Compounding Market - Global Forecast 2026-2032 - Product Image

Animal Drug Compounding Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Animal Drug Compounding Market Report 2026 - Product Image

Animal Drug Compounding Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Animal Drug Compounding Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Animal Drug Compounding Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Animal Drug Compounding - Global Strategic Business Report - Product Image

Animal Drug Compounding - Global Strategic Business Report

  • Report
  • 369 Pages
  • Global
From
Animal Drug Compounding Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Animal Drug Compounding Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.